{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:14:18Z","timestamp":1789596858986,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.rmed.2016.05.025","type":"journal-article","created":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T18:49:44Z","timestamp":1464202184000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Long-term effects of azithromycin in patients with cystic fibrosis"],"prefix":"10.1016","volume":"117","author":[{"given":"Cl\u00e9mentine","family":"Samson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Tamalet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoang Vu","family":"Thien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Taytard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Perisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Boelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"Corvol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4922","key":"10.1016\/j.rmed.2016.05.025_bib1","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"issue":"9358","key":"10.1016\/j.rmed.2016.05.025_bib2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(03)12567-6","article-title":"Cystic fibrosis","volume":"361","author":"Ratjen","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.rmed.2016.05.025_bib3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/thorax.56.3.237","article-title":"Cystic fibrosis","volume":"56","author":"Robinson","year":"2001","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.rmed.2016.05.025_bib4","doi-asserted-by":"crossref","first-page":"L588","DOI":"10.1152\/ajplung.00013.2005","article-title":"Adherence of airway neutrophils and inflammatory response are increased in CF airway epithelial cell-neutrophil interactions","volume":"290","author":"Tabary","year":"2006","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"6","key":"10.1016\/j.rmed.2016.05.025_bib5","doi-asserted-by":"crossref","first-page":"L997","DOI":"10.1152\/ajplung.00156.2002","article-title":"Distinct cytokine production by lung and blood neutrophils from children with cystic fibrosis","volume":"284","author":"Corvol","year":"2003","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"2","key":"10.1016\/j.rmed.2016.05.025_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/01.qco.0000160901.71813.fe","article-title":"Immunomodulatory effects of antimicrobials in the therapy of respiratory tract infections","volume":"18","author":"Parnham","year":"2005","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.rmed.2016.05.025_bib7","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.biocel.2011.05.009","article-title":"Macrolides: new therapeutic perspectives in lung diseases","volume":"43","author":"Guillot","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2 Suppl","key":"10.1016\/j.rmed.2016.05.025_bib8","article-title":"Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa","volume":"125","author":"Wozniak","year":"2004","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2016.05.025_bib9","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1128\/AAC.01403-10","article-title":"Restoration of chloride efflux by azithromycin in airway epithelial cells of cystic fibrosis patients","volume":"55","author":"Saint-Criq","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl 9A","key":"10.1016\/j.rmed.2016.05.025_bib10","article-title":"Applying lessons learned in the treatment of diffuse panbronchiolitis to other chronic inflammatory diseases","volume":"117","author":"Kudoh","year":"2004","journal-title":"Am. J. Med."},{"issue":"6 Pt 1","key":"10.1016\/j.rmed.2016.05.025_bib11","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1164\/ajrccm.157.6.9710075","article-title":"Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin","volume":"157","author":"Kudoh","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"12","key":"10.1016\/j.rmed.2016.05.025_bib12","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/thx.50.12.1246","article-title":"Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection","volume":"50","author":"Fujii","year":"1995","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.rmed.2016.05.025_bib13","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0954-6111(03)00042-8","article-title":"Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis","volume":"97","author":"Kadota","year":"2003","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2016.05.025_bib14","article-title":"Macrolide antibiotics for cystic fibrosis","volume":"11","author":"Southern","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.rmed.2016.05.025_bib15","first-page":"725","article-title":"Changes in the normal maximal expiratory flow-volume curve with growth and aging","volume":"127","author":"Knudson","year":"1983","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.rmed.2016.05.025_bib16","series-title":"Microbiology and Infectious Disease in Cystic Fibrosis","first-page":"1","author":"Foundation","year":"1994"},{"issue":"9","key":"10.1016\/j.rmed.2016.05.025_bib17","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"Flume","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2016.05.025_bib18","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1128\/JCM.43.7.3467-3470.2005","article-title":"Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis","volume":"43","author":"Pierre-Audigier","year":"2005","journal-title":"J.\u00a0Clin. Microbiol."},{"issue":"6","key":"10.1016\/j.rmed.2016.05.025_bib19","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1164\/rccm.200207-679OC","article-title":"Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease","volume":"167","author":"Olivier","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.rmed.2016.05.025_bib20","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1164\/rccm.200207-678OC","article-title":"Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis","volume":"167","author":"Olivier","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9338","key":"10.1016\/j.rmed.2016.05.025_bib21","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(02)11081-6","article-title":"Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial","volume":"360","author":"Equi","year":"2002","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.rmed.2016.05.025_bib22","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.290.13.1749","article-title":"Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial","volume":"290","author":"Saiman","year":"2003","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.rmed.2016.05.025_bib23","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.rmed.2008.03.009","article-title":"Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection","volume":"102","author":"Steinkamp","year":"2008","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.rmed.2016.05.025_bib24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/thorax.57.3.212","article-title":"Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial","volume":"57","author":"Wolter","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2016.05.025_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002203.pub2","article-title":"Macrolide antibiotics for cystic fibrosis","volume":"2","author":"Southern","year":"2004","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"10.1016\/j.rmed.2016.05.025_bib26","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/thx.2005.057950","article-title":"Long term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled trial","volume":"61","author":"Clement","year":"2006","journal-title":"Thorax"},{"issue":"17","key":"10.1016\/j.rmed.2016.05.025_bib27","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.2010.563","article-title":"Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial","volume":"303","author":"Saiman","year":"2010","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.rmed.2016.05.025_bib28","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/jac\/dkr040","article-title":"Effectiveness and safety of macrolides in cystic fibrosis patients: a meta-analysis and systematic review","volume":"66","author":"Cai","year":"2011","journal-title":"J.\u00a0Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.rmed.2016.05.025_bib29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.inf.0000247109.44249.ac","article-title":"Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function","volume":"26","author":"Tramper-Stranders","year":"2007","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"3","key":"10.1016\/j.rmed.2016.05.025_bib30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jcf.2015.03.012","article-title":"Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis","volume":"14","author":"Parkins","year":"2015","journal-title":"J.\u00a0Cyst. Fibros."},{"issue":"9944","key":"10.1016\/j.rmed.2016.05.025_bib31","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0140-6736(14)61136-3","article-title":"The role of the microbiome in exacerbations of chronic lung diseases","volume":"384","author":"Dickson","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.rmed.2016.05.025_bib32","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S2213-2600(13)70038-9","article-title":"Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases","volume":"1","author":"Serisier","year":"2013","journal-title":"Lancet Respir. Med."},{"issue":"3","key":"10.1016\/j.rmed.2016.05.025_bib33","doi-asserted-by":"crossref","first-page":"e798","DOI":"10.1542\/peds.2011-1198","article-title":"Macrolide treatment failure in streptococcal pharyngitis resulting in acute rheumatic fever","volume":"129","author":"Logan","year":"2012","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.rmed.2016.05.025_bib34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2165\/00044011-199816020-00009","article-title":"A\u00a0phase I determination of azithromycin in plasma during a 6-Week period in normal volunteers after a standard dose of 500mg once daily for 3 days","volume":"16","author":"Crokaert","year":"1998","journal-title":"Clin. Drug Investig."},{"issue":"8","key":"10.1016\/j.rmed.2016.05.025_bib35","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1128\/AAC.00663-13","article-title":"Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients","volume":"57","author":"Kawai","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.rmed.2016.05.025_bib36","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/bph.12574","article-title":"Azithromycin analogue CSY0073 attenuates lung inflammation induced by LPS challenge","volume":"171","author":"Balloy","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.rmed.2016.05.025_bib37","doi-asserted-by":"crossref","first-page":"L746","DOI":"10.1152\/ajplung.00292.2012","article-title":"Nonantibiotic macrolides prevent human neutrophil elastase-induced mucus stasis and airway surface liquid volume depletion","volume":"304","author":"Tarran","year":"2013","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"5","key":"10.1016\/j.rmed.2016.05.025_bib38","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/bph.12187","article-title":"A\u00a0novel macrolide\/fluoroketolide, solithromycin (CEM-101), reverses corticosteroid insensitivity via phosphoinositide 3-kinase pathway inhibition","volume":"169","author":"Kobayashi","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.rmed.2016.05.025_bib39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1124\/jpet.112.200733","article-title":"A\u00a0novel macrolide solithromycin exerts superior anti-inflammatory effect via NF-kappaB inhibition","volume":"345","author":"Kobayashi","year":"2013","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.rmed.2016.05.025_bib40","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1473-3099(16)00017-7","article-title":"Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL)","volume":"16","author":"Barrera","year":"2016","journal-title":"Lancet Infect. Dis."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611116301123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611116301123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:34:14Z","timestamp":1760614454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611116301123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":40,"alternative-id":["S0954611116301123"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2016.05.025","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term effects of azithromycin in patients with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2016.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}